Porous tip contact force-sensing catheters for pulmonary vein isolation: performance in a clinical routine setting.


Journal

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 21 02 2019
accepted: 10 07 2019
pubmed: 20 7 2019
medline: 26 1 2021
entrez: 20 7 2019
Statut: ppublish

Résumé

In catheter ablation of atrial fibrillation (AF), contact force (CF)-sensing catheters with an irrigated tip are used to deliver radiofrequency (RF) energy to the tissue. The ThermoCool® Smarttouch™ Surroundflow catheter (STSF) integrates CF-sensing technology and a new porous tip for advanced external cooling. The aim was to evaluate the performance and safety of STSF in a clinical setting of pulmonary vein isolation (PVI) in comparison with standard contact force-sensing catheter (ST). We assigned consecutive patients (n = 80, prospectively, open-label, non-randomized) with symptomatic AF to either PVI with STSF (n = 60) or ST (n = 20). Total ablation time to achieve PVI was significantly shorter in STSF compared to that in ST (STSF, 1556 ± 435 s vs. ST, 1922 ± 961 s; p = 0.045). Ablation time to achieve loss of pace capture of left pulmonary veins was shorter using STSF (left veins, 155 ± 140 s vs. 291 ± 188 s; p = 0.01; right veins, 208 ± 196 s vs. 369 ± 306 s; p = 0.09). Furthermore, administered irrigation fluid was significantly reduced in STSF (241.4 ± 79.6 ml vs. 540.3 ± 229.5 ml; p < 0.01). CF was lower during ablation of left pulmonary veins. One steam pop occurred in STSF, which did not lead to pericardial effusion (vs. no steam pop in ST). The Kaplan-Meier estimate 12-month AF recurrence was 34.3% and 37.7% (p = 0.8). Integrating CF technology and the porous tip technology enables effective energy transfer to the tissue resulting in shorter ablation time and less irrigation fluid administration. In our cohort, PVI using the STSF was not associated with an increased complication rate or AF recurrence rate after 12-month follow-up when compared with the ST.

Identifiants

pubmed: 31321659
doi: 10.1007/s10840-019-00591-2
pii: 10.1007/s10840-019-00591-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-259

Références

J Am Coll Cardiol. 2002 Aug 7;40(3):464-74
pubmed: 12142112
Europace. 2016 Apr;18(4):531-7
pubmed: 26346921
Eur Heart J. 2016 Oct 07;37(38):2858-2865
pubmed: 27381589
J Am Coll Cardiol. 2015 Dec 22;66(24):2743-2752
pubmed: 26700836
J Cardiovasc Electrophysiol. 2013 Dec;24(12):1328-35
pubmed: 23889915
Heart Rhythm. 2014 Nov;11(11):1919-24
pubmed: 25068575
J Cardiovasc Electrophysiol. 2017 Sep;28(9):994-1005
pubmed: 28569422
Clin Res Cardiol. 2018 Nov;107(11):1003-1012
pubmed: 29740700
N Engl J Med. 2018 Feb 01;378(5):417-427
pubmed: 29385358
J Cardiovasc Electrophysiol. 2017 Jan;28(1):109-114
pubmed: 27653802
Europace. 2017 Aug 1;19(8):1317-1321
pubmed: 27702870
JACC Clin Electrophysiol. 2016 Nov;2(6):691-699
pubmed: 29759747
J Cardiovasc Electrophysiol. 2016 Jan;27(1):102-9
pubmed: 26359632
Eur Heart J. 2018 Aug 7;39(30):2767-2768
pubmed: 30107429
Heart Rhythm. 2016 Sep;13(9):1761-7
pubmed: 27173976
J Cardiovasc Electrophysiol. 2014 Aug;25(8):852-858
pubmed: 24602038
J Interv Card Electrophysiol. 2014 Apr;39(3):193-200
pubmed: 24557861
Heart Rhythm. 2017 Oct;14(10):e275-e444
pubmed: 28506916
J Cardiovasc Electrophysiol. 2015 Sep;26(9):956-962
pubmed: 26062031
Circulation. 2015 Sep 8;132(10):907-15
pubmed: 26260733
J Cardiovasc Electrophysiol. 2015 Oct;26(10):1075-80
pubmed: 26183341
J Am Coll Cardiol. 2014 Aug 19;64(7):647-56
pubmed: 25125294
N Engl J Med. 2008 Oct 23;359(17):1778-85
pubmed: 18946063
Circ Arrhythm Electrophysiol. 2008 Dec;1(5):354-62
pubmed: 19808430
J Cardiovasc Electrophysiol. 2002 Nov;13(11):1067-73
pubmed: 12475093
J Cardiovasc Electrophysiol. 2010 Sep;21(9):1038-43
pubmed: 20367658
Clin Res Cardiol. 2016 Sep;105(9):738-43
pubmed: 27048420
J Interv Card Electrophysiol. 2014 Apr;39(3):225-32
pubmed: 24532109
Europace. 2018 Nov 1;20(FI_3):f392-f400
pubmed: 29016769

Auteurs

Tobias Plenge (T)

Department of Electrophysiology, Heart Center, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany. tobias.plenge@uk-koeln.de.

Jan-Hendrik van den Bruck (JH)

Department of Electrophysiology, Heart Center, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Jakob Lüker (J)

Department of Electrophysiology, Heart Center, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Arian Sultan (A)

Department of Electrophysiology, Heart Center, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Daniel Steven (D)

Department of Electrophysiology, Heart Center, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH